ONECUT2 and prostate cancer: The investigators further showed that CSRM617 can inhibit cell growth and induce apoptosis in vitro in several prostate cancer cell lines that express moderate to high levels of ONECUT2 and that the compound can suppress prostate cancer growth and metastasis in a nude mouse model system.